These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26828136)

  • 1. A novel cell cycle-associated lncRNA, HOXA11-AS, is transcribed from the 5-prime end of the HOXA transcript and is a biomarker of progression in glioma.
    Wang Q; Zhang J; Liu Y; Zhang W; Zhou J; Duan R; Pu P; Kang C; Han L
    Cancer Lett; 2016 Apr; 373(2):251-9. PubMed ID: 26828136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma.
    Zhang JX; Han L; Bao ZS; Wang YY; Chen LY; Yan W; Yu SZ; Pu PY; Liu N; You YP; Jiang T; Kang CS;
    Neuro Oncol; 2013 Dec; 15(12):1595-603. PubMed ID: 24203894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long Noncoding RNA HOXA11-AS Functions as miRNA Sponge to Promote the Glioma Tumorigenesis Through Targeting miR-140-5p.
    Cui Y; Yi L; Zhao JZ; Jiang YG
    DNA Cell Biol; 2017 Oct; 36(10):822-828. PubMed ID: 28832185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of HOXA11-AS/miR-214-3p/EZH2 axis on the growth, migration and invasion of glioma cells.
    Xu C; He T; Li Z; Liu H; Ding B
    Biomed Pharmacother; 2017 Nov; 95():1504-1513. PubMed ID: 28946213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNA homeobox (HOX) A11-AS promotes malignant progression of glioma by targeting miR-124-3p.
    Yang JX; Liu B; Yang BY; Meng Q
    Neoplasma; 2018; 65(4):505-514. PubMed ID: 30064227
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Long Noncoding RNA ZEB1-AS1 Promotes Tumorigenesis and Predicts Poor Prognosis in Glioma.
    Lv QL; Hu L; Chen SH; Sun B; Fu ML; Qin CZ; Qu Q; Wang GH; He CJ; Zhou HH
    Int J Mol Sci; 2016 Aug; 17(9):. PubMed ID: 27589728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of lncRNA HOXA11-AS/miR-124 Axis Inhibits Glioma Progression.
    He Y; Qiu X
    Cell Biochem Biophys; 2021 Dec; 79(4):815-822. PubMed ID: 34117619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA MALAT1 associates with the malignant status and poor prognosis in glioma.
    Ma KX; Wang HJ; Li XR; Li T; Su G; Yang P; Wu JW
    Tumour Biol; 2015 May; 36(5):3355-9. PubMed ID: 25613066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A long noncoding RNA UCA1 promotes proliferation and predicts poor prognosis in glioma.
    Zhao W; Sun C; Cui Z
    Clin Transl Oncol; 2017 Jun; 19(6):735-741. PubMed ID: 28105536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The long noncoding RNA HOXA11 antisense induces tumor progression and stemness maintenance in cervical cancer.
    Kim HJ; Eoh KJ; Kim LK; Nam EJ; Yoon SO; Kim KH; Lee JK; Kim SW; Kim YT
    Oncotarget; 2016 Dec; 7(50):83001-83016. PubMed ID: 27792998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
    Wang SJ; Wang H; Zhao CD; Li R
    Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6358-6368. PubMed ID: 30338804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Upregulation of long noncoding RNA HOXA-AS3 promotes tumor progression and predicts poor prognosis in glioma.
    Wu F; Zhang C; Cai J; Yang F; Liang T; Yan X; Wang H; Wang W; Chen J; Jiang T
    Oncotarget; 2017 Aug; 8(32):53110-53123. PubMed ID: 28881797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Underexpression of HOXA11 Is Associated with Treatment Resistance and Poor Prognosis in Glioblastoma.
    Se YB; Kim SH; Kim JY; Kim JE; Dho YS; Kim JW; Kim YH; Woo HG; Kim SH; Kang SH; Kim HJ; Kim TM; Lee ST; Choi SH; Park SH; Kim IH; Kim DG; Park CK
    Cancer Res Treat; 2017 Apr; 49(2):387-398. PubMed ID: 27456940
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
    Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
    Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT-1 expression is regulated by IGFBP-3 in malignant glioma cells and is a strong predictor of poor survival in patients with glioblastoma.
    Thota B; Arimappamagan A; Kandavel T; Shastry AH; Pandey P; Chandramouli BA; Hegde AS; Kondaiah P; Santosh V
    J Neurosurg; 2014 Aug; 121(2):374-83. PubMed ID: 24878287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HOXA11 antisense long noncoding RNA (HOXA11-AS): A promising lncRNA in human cancers.
    Lu CW; Zhou DD; Xie T; Hao JL; Pant OP; Lu CB; Liu XF
    Cancer Med; 2018 Aug; 7(8):3792-3799. PubMed ID: 29992790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HOTTIP-Mediated HOXA11 Expression Promotes Cell Growth, Migration and Inhibits Cell Apoptosis in Breast Cancer.
    Sun Y; Zeng C; Gan S; Li H; Cheng Y; Chen D; Li R; Zhu W
    Int J Mol Sci; 2018 Feb; 19(2):. PubMed ID: 29415429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MDC1-AS, an antisense long noncoding RNA, regulates cell proliferation of glioma.
    Yue H; Zhu J; Xie S; Li F; Xu Q
    Biomed Pharmacother; 2016 Jul; 81():203-209. PubMed ID: 27261595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA HOXA11-AS Promotes Proliferation and Invasion of Gastric Cancer by Scaffolding the Chromatin Modification Factors PRC2, LSD1, and DNMT1.
    Sun M; Nie F; Wang Y; Zhang Z; Hou J; He D; Xie M; Xu L; De W; Wang Z; Wang J
    Cancer Res; 2016 Nov; 76(21):6299-6310. PubMed ID: 27651312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HOTAIRM1, an enhancer lncRNA, promotes glioma proliferation by regulating long-range chromatin interactions within HOXA cluster genes.
    Shi T; Guo D; Xu H; Su G; Chen J; Zhao Z; Shi J; Wedemeyer M; Attenello F; Zhang L; Lu W
    Mol Biol Rep; 2020 Apr; 47(4):2723-2733. PubMed ID: 32180085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.